COQ8B is a human gene. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
The COQ8B gene (also known as ADCK4 — aarF domain containing kinase 4) encodes a mitochondrial protein essential for coenzyme Q (ubiquinone) biosynthesis. CoQ8B functions as a protein kinase within the coenzyme Q biosynthesis pathway, and mutations in this gene cause both hereditary glomerulonephropathy and have been implicated in Parkinson's disease pathogenesis.
| Attribute |
Value |
| Gene Symbol |
COQ8B (ADCK4) |
| Official Full Name |
Coenzyme Q8B (AarF domain containing kinase 4) |
| Chromosomal Location |
19q13.2 |
| Gene ID |
79934 |
| UniProt ID |
Q9GZX4 |
| Protein Class |
Protein kinase, mitochondrial |
¶ Protein Structure and Function
COQ8B is a 678-amino acid mitochondrial protein with the following domains:
- AarF Domain: The signature domain containing kinase activity
- N-terminal Mitochondrial Targeting Sequence: Directs protein to mitochondria
- Transmembrane Domains: For mitochondrial membrane association
- C-terminal Regulatory Domain: Modulates kinase activity
COQ8B (along with its paralog COQ8A) is essential for the biosynthesis of coenzyme Q (CoQ), also known as ubiquinone. This is a critical lipid-soluble electron carrier in the mitochondrial electron transport chain:
- Kinase Activity: COQ8B phosphorylates intermediate compounds in the CoQ biosynthesis pathway
- Complex Assembly: Helps assemble the multi-enzyme CoQ biosynthesis complex
- CoQ10 Production: Directs production of CoQ10 (ubiquinone-10)
- Mitochondrial Quality Control: Maintains proper electron transport chain function
Coenzyme Q (CoQ) is essential for:
- Electron Transfer: Complex I and II transfer electrons to CoQ
- ATP Production: Via oxidative phosphorylation
- Antioxidant Protection: CoQ neutralizes reactive oxygen species (ROS)
- Mitochondrial Membrane Potential: Maintains proper mitochondrial function
COQ8B is expressed ubiquitously with high expression in:
- Kidney: Especially glomerular cells (podocytes)
- Brain: Neurons, particularly dopaminergic neurons
- Heart: Cardiomyocytes
- Muscle: Skeletal muscle fibers
- Liver: Hepatocytes
Mitochondrial localization is confirmed in all cell types.
COQ8B is critical for:
- Respiratory Chain Support: Ensuring proper electron flow
- ATP Synthesis: Via oxidative phosphorylation
- ROS Management: Reducing mitochondrial oxidative stress
- Mitochondrial Dynamics: Fusion and fission regulation
In neurons, COQ8B provides:
- Neuroprotection: Against mitochondrial toxins
- Dopaminergic Neuron Survival: Critical for PD-affected neurons
- Synaptic Function: Maintaining synaptic energy supply
In kidney glomeruli, COQ8B maintains:
- Podocyte Integrity: Slit diaphragm function
- Filtration Barrier: Proper glomerular filtration
- Cell Survival: Preventing podocyte apoptosis
Biallelic mutations in COQ8B cause:
- Disease: Familial steroid-resistant nephrotic syndrome
- Inheritance: Autosomal recessive
- Onset: Usually childhood
- Features:
- Proteinuria
- Hypoalbuminemia
- Edema
- Progressive renal failure
- Treatment: CoQ10 supplementation may help some patients
COQ8B variants are implicated in PD through:
- Mitochondrial Dysfunction: Impaired CoQ production affects Complex I
- Dopaminergic Neuron Vulnerability: Reduced energy and increased ROS
- Genetic Association: COQ8B variants modify PD risk
GWAS and sequencing studies have identified COQ8B variants in PD patients:
- Increased risk of sporadic PD
- Earlier age of onset in carriers
- More severe phenotype
- Cardiomyopathy: Some COQ8B variants associated with cardiac issues
- Hearing Loss: Secondary to kidney disease
- Neurological Symptoms: In some patients with COQ8B mutations
COQ8B interacts with:
- COQ1 (PDS1) - First step enzyme
- COQ2 - Para-hydroxybenzoate polyprenyltransferase
- COQ3 - O-methyltransferase
- COQ4 - Complex assembly
- COQ5 - C-terminal methylation
- COQ6 - Hydroxylase
- COQ7 - Final step, converting DMQH2 to CoQ
- COQ8A (ADCK3) - Paralog with overlapping function
- COQ9 - Essential cofactor
- COQ10 - Product itself
- Complex I subunits (NDUFS1, NDUFV1)
- Complex II subunits
- Mitochondrial DNA polymerase
- PINK1 (PD mitophagy protein)
- Parkin
Over 40 pathogenic variants identified:
- Missense mutations: Most common
- Nonsense mutations: Truncated proteins
- Splice site mutations: Aberrant splicing
Common variants:
- c.1045G>A (p.G349S)
- c.901C>T (p.R301*)
- c.638G>A (p.R213Q)
SNPs studied in PD:
- rs12239046: Associated with PD risk
- rs72552286: In regulatory region
| Treatment |
Mechanism |
Status |
| CoQ10 Supplementation |
Bypass defective biosynthesis |
Clinical trials in PD |
| CoQ10 Analogs |
Synthetic analogs |
Preclinical |
| Gene Therapy |
Restore COQ8B function |
Research |
| Mitochondrial Protectants |
Enhance mitochondrial function |
Various stages |
Multiple clinical trials have tested CoQ10 in PD:
- High-dose CoQ10 (1200-3000 mg/day) showed promise in early trials
- Later large trials showed mixed results
- May benefit patients with specific genotypes (including COQ8B variants)
- Knockout mice: Embryonic lethal, demonstrating essential function
- Conditional knockouts: Tissue-specific deletions
- Zebrafish: coq8b morphants show renal phenotypes
- C. elegans: For pathway studies
- Patient-derived podocytes: From SRNS patients
- iPSC-derived neurons: From PD patients
- Yeast models: COQ pathway conservation
COQ8B encodes a critical enzyme for coenzyme Q biosynthesis, linking mitochondrial function to both kidney disease (SRNS) and Parkinson's disease. Understanding this gene's function illuminates:
- The importance of mitochondrial health in dopaminergic neurons
- Why CoQ10 supplementation helps some patients
- Potential therapeutic targets for neurodegenerative disease
The connection between CoQ biosynthesis and neurodegeneration makes COQ8B an important gene for understanding Parkinson's disease pathogenesis.